Evolus, Inc. Board of Directors

Evolus, Inc., a performance beauty company, focuses on delivering products in the cash-pay aesthetic market in the United States, Canada, and Europe. The company offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults; and Nuceiva, for the temporary improvement in the appearance of moderate to severe vertical lines between the eyebrows seen at maximum frown. It also provides dermal filler products under the Estyme and Evolysse names. The company was incorporated in 2012 and is headquartered in Newport Beach, California.

Mr. David Moatazedi

Mr. David Moatazedi

President, CEO & Director

Mr. Nareg Sagherian

Mr. Nareg Sagherian

Head of Global Investor Relations & Corporate Communications

Ms. Sandra Beaver

Ms. Sandra Beaver

Chief Financial Officer

Ms. Jessica Novak

Ms. Jessica Novak

Senior Vice President of Human Resources

Mr. Kurt Knab

Mr. Kurt Knab

Senior Vice President of Sales

Dr. Rui Avelar C.CFP, Dip.SportMed, M.D.

Dr. Rui Avelar C.CFP, Dip.SportMed, M.D.

Chief Medical Officer and Head of Research & Development

Leaving Board of Directors Review Your about to visit the following url Invalid URL

Loading...
Comments


Comment created.